Oncology
Precision-driven oncology clinical trials
In recent years, there has been a shift from the traditional organ-based studies focusing on cytotoxic chemotherapy to a more targeted approach. Biomarker-driven trials have emerged using molecularly targeted agents that interfere with crucial cell signaling mechanisms or immune responses to cancer in specific patient subsets. This paradigm shift emphasizes the significance of clinical trials in oncology.
Accelsiors recognizes and embraces the ongoing changes in scientific, methodological, practical, and patient-focused aspects of oncology trials. We actively participate in the necessary transformation of these trials to stay at the forefront of advancements in the field. Wanna stay ahead?
Our expertise in Oncology:
- Over 1,000 site connections worldwide
- Access to >3 million patients across the globe Over 12,000 patients randomized
- Over 16,000 patients screened
Innovative approaches in cancer immunotherapy
With cancer immunotherapy transforming outcomes, we help clients capitalize on cutting-edge approaches like combination therapies, neo-adjuvants, and biomarkers. Extensive Phase I-III experience in difficult therapeutic areas such as rare diseases and proprietary methodology for trial acceleration enable us to expedite oncology drug development.
Expertise in global oncology research
We tap into academia through our Academic Research Organization, forging partnerships with leading cancer research institutions. By pursuing clinical partnerships in oncology, we can deliver life-changing treatments from bench to bedside. Our Oncology Leadership Team has over 50 combined years of experience designing and operating cancer clinical trials from Phase I-III. Also, cross-functional collaboration with our wider Clinical Operations team, which has supported numerous global trials, ensures excellence in oncology protocols.
Main regions are served by top professionals:
- USA = 20 FTE’s (covering more than 80 medical centers and 600 active patients)
- Europe = 120 FTE’s
- Rest of World = 100 FTE’s
